Genetic variation in the interleukin - 28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection
Francesco Marabita(Karolinska University Hospital), Massimo Colombo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Sergio Abrignani(Istituto Nazionale Genetica Molecolare), Cristina Cheroni(Human Technopole), Raffaele De Francesco(University of Milan), R. Soffredini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alessio Aghemo, Marco Crimi(Istituto Nazionale Genetica Molecolare), Maria Grazia Rumi(University of Milan), Rossana Scavelli(Istituto Nazionale Genetica Molecolare), Stella De Nicola(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 125
Related Papers
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
The natural history of compensated cirrhosis due to hepatitis C virus
|Hepatology|2006|631